Campral (Page 4 of 4)

Campral

Label ImageLabel Image
CAMPRAL
acamprosate calcium tablet, delayed release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68151-4760(NDC:0456-3330)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
acamprosate calcium (acamprosate) acamprosate calcium 333 mg
Inactive Ingredients
Ingredient Name Strength
CROSPOVIDONE
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM SILICATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
SILICON DIOXIDE
MAGNESIUM STEARATE
TALC
PROPYLENE GLYCOL
METHACRYLIC ACID — ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
Product Characteristics
Color WHITE (WHITE) Score no score
Shape ROUND (ROUND) Size 10mm
Flavor Imprint Code 333
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68151-4760-0 1 TABLET, DELAYED RELEASE in 1 PACKAGE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021431 01/11/2005
Labeler — Carilion Materials Management (079239644)
Registrant — Carilion Materials Management (079239644)
Establishment
Name Address ID/FEI Operations
Carilion Materials Management 079239644 REPACK (68151-4760)

Revised: 08/2016 Carilion Materials Management

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.